$KWIK
KwikClick, Inc.

2023 Q3 Form 10-Q Financial Statement

#000109690623001604 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $91.09K $51.48K $222.2K
YoY Change -45.37% -76.83%
Cost Of Revenue $88.55K $40.52K $32.91K
YoY Change -30.02% 23.13%
Gross Profit $2.542K $10.96K $189.3K
YoY Change -93.68% -94.21%
Gross Profit Margin 2.79% 21.28% 85.19%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $182.0K $265.7K $272.0K
YoY Change -28.84% -2.32%
% of Gross Profit 7158.34% 2425.62% 143.73%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $182.0K $832.1K $1.572M
YoY Change -81.92% -47.07% 373.48%
Operating Profit -$179.4K -$821.2K -$1.350M
YoY Change -78.64% -39.17% 306.56%
Interest Expense $25.39K $12.82K $0.00
YoY Change 314.5%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.190M -$793.5K -$1.350M
YoY Change 41.64% -41.22%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.190M -$793.5K -$1.350M
YoY Change 41.64% -41.22% 306.56%
Net Earnings / Revenue -1306.12% -1541.38% -607.59%
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 151.1M shares 149.4M shares
Diluted Shares Outstanding 151.1M shares 150.5M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $27.63K $33.57K $15.46K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $27.63K $33.57K $65.46K
YoY Change 12.89% -48.72%
LONG-TERM ASSETS
Property, Plant & Equipment $4.792K $5.069K $6.177K
YoY Change -18.78% -17.94%
Goodwill
YoY Change
Intangibles $1.490M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.573M $1.536M $932.1K
YoY Change 59.01% 64.76%
TOTAL ASSETS
Total Short-Term Assets $27.63K $33.57K $65.46K
Total Long-Term Assets $1.573M $1.536M $932.1K
Total Assets $1.601M $1.569M $997.6K
YoY Change 57.89% 57.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $954.7K $823.3K $513.4K
YoY Change 138.44% 60.35%
Accrued Expenses $147.7K $123.8K $41.44K
YoY Change 85.1% 198.75%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.650M $2.083M $1.495M
YoY Change 117.22% 39.34%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.650M $2.083M $1.495M
Total Long-Term Liabilities
Total Liabilities $2.674M $2.121M $1.588M
YoY Change 105.47% 33.5%
SHAREHOLDERS EQUITY
Retained Earnings -$9.340M -$8.150M -$4.826M
YoY Change 64.86% 68.9%
Common Stock $15.14K $15.07K $11.80K
YoY Change 17.47% 27.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.074M -$551.2K -$590.8K
YoY Change
Total Liabilities & Shareholders Equity $1.601M $1.569M $997.6K
YoY Change 57.89% 57.31%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.190M -$793.5K -$1.350M
YoY Change 41.64% -41.22% 306.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001884164
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56349
dei Entity Registrant Name
EntityRegistrantName
KwikClick, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4463033
dei Entity Address Address Line1
EntityAddressAddressLine1
585 West 500 South
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 130
dei Entity Address City Or Town
EntityAddressCityOrTown
Bountiful
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84010
dei City Area Code
CityAreaCode
385
dei Local Phone Number
LocalPhoneNumber
301-2792
dei Phone Fax Number Description
PhoneFaxNumberDescription
Registrant’s telephone number, including area code
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
151113705 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33568 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30583 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
33568 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
30583 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5069 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5623 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1438751 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1066780 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
91968 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
118684 usd
CY2023Q2 us-gaap Assets
Assets
1569356 usd
CY2022Q4 us-gaap Assets
Assets
1221670 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
823263 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
546807 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
123786 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
124551 usd
CY2023Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
55852 usd
CY2022Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
54295 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
779739 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2023Q2 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
300000 usd
CY2022Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
4010 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2082640 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
729663 usd
CY2023Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
37938 usd
CY2022Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
66053 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2120578 usd
CY2022Q4 us-gaap Liabilities
Liabilities
795716 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150713705 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150713705 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149442605 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149442605 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
15072 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
14945 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7583998 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7430721 usd
CY2023Q2 fil Subscription Receivable
SubscriptionReceivable
0 usd
CY2022Q4 fil Subscription Receivable
SubscriptionReceivable
-520261 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8150292 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6499451 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-551222 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
425954 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1569356 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1221670 usd
CY2023Q2 fil Brand Services Revenue
BrandServicesRevenue
51478 usd
CY2022Q2 fil Brand Services Revenue
BrandServicesRevenue
72189 usd
fil Brand Services Revenue
BrandServicesRevenue
136795 usd
fil Brand Services Revenue
BrandServicesRevenue
176100 usd
CY2023Q2 fil Software Licensing Revenue
SoftwareLicensingRevenue
0 usd
CY2022Q2 fil Software Licensing Revenue
SoftwareLicensingRevenue
150000 usd
fil Software Licensing Revenue
SoftwareLicensingRevenue
0 usd
fil Software Licensing Revenue
SoftwareLicensingRevenue
300000 usd
CY2023Q2 us-gaap Revenues
Revenues
51478 usd
CY2022Q2 us-gaap Revenues
Revenues
222189 usd
us-gaap Revenues
Revenues
136795 usd
us-gaap Revenues
Revenues
476100 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
40523 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
32912 usd
us-gaap Cost Of Revenue
CostOfRevenue
70682 usd
us-gaap Cost Of Revenue
CostOfRevenue
80030 usd
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
293015 usd
CY2022Q2 us-gaap Management Fee Expense
ManagementFeeExpense
993035 usd
us-gaap Management Fee Expense
ManagementFeeExpense
576053 usd
us-gaap Management Fee Expense
ManagementFeeExpense
1494301 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
265727 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
272040 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
462895 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
669297 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
232859 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
274200 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
664898 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
505322 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
832124 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1572187 usd
us-gaap Operating Expenses
OperatingExpenses
1774528 usd
us-gaap Operating Expenses
OperatingExpenses
2748950 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
12824 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
13108 usd
us-gaap Interest Expense
InterestExpense
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-793470 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1349998 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1650841 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2272850 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-793470 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1349998 usd
us-gaap Net Income Loss
NetIncomeLoss
-1650841 usd
us-gaap Net Income Loss
NetIncomeLoss
-2272850 usd
CY2023Q2 fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
CY2022Q2 fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
fil Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.02
CY2023Q2 fil Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
150466827 shares
CY2022Q2 fil Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
117240353 shares
fil Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
150156441 shares
fil Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
116580147 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
425954 usd
CY2023Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
4010 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
60000 usd
CY2023Q1 fil Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
520261 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-857371 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
152854 usd
CY2023Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
62700 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
26694 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-793470 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-551222 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-812394 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-922852 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1735246 usd
CY2022Q2 fil Issuance Of Common Stock For Settlement Of Stock Issuable
IssuanceOfCommonStockForSettlementOfStockIssuable
1041200 usd
CY2022Q2 fil Issuance Of Common Stock For Accrued Compensation
IssuanceOfCommonStockForAccruedCompensation
333334 usd
CY2022Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1019864 usd
CY2022Q2 fil Issuance Of Common Stock For Intellectual Property Acquisition
IssuanceOfCommonStockForIntellectualPropertyAcquisition
100000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1349998 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-590846 usd
us-gaap Net Income Loss
NetIncomeLoss
-1650841 usd
us-gaap Net Income Loss
NetIncomeLoss
-2272850 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
42174 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17276 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-149395 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1019864 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-560 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
158 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
757 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-765 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18876 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
276456 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-59378 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1183424 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1324895 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
413591 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
84769 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1920 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6656 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-413591 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-89505 usd
fil Refund Of Stock Payable
RefundOfStockPayable
0 usd
fil Refund Of Stock Payable
RefundOfStockPayable
-30000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
779739 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
850000 usd
fil Proceeds From Common Stock Issuable
ProceedsFromCommonStockIssuable
300000 usd
fil Proceeds From Common Stock Issuable
ProceedsFromCommonStockIssuable
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
fil Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
520261 usd
fil Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1600000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
820000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2985 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-594400 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30583 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
609862 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33568 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15462 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
fil Common Stock Issued For Intellectual Property
CommonStockIssuedForIntellectualProperty
0 usd
fil Common Stock Issued For Intellectual Property
CommonStockIssuedForIntellectualProperty
100000 usd
fil Common Stock Issued For Stock Issuable Settlement
CommonStockIssuedForStockIssuableSettlement
0 usd
fil Common Stock Issued For Stock Issuable Settlement
CommonStockIssuedForStockIssuableSettlement
1041200 usd
fil Common Stock Issued For Accrued Compensation
CommonStockIssuedForAccruedCompensation
0 usd
fil Common Stock Issued For Accrued Compensation
CommonStockIssuedForAccruedCompensation
333334 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
157097 usd
fil Capital Contribution For Settlement Of Stock Issuable
CapitalContributionForSettlementOfStockIssuable
4010 usd
fil Capital Contribution For Settlement Of Stock Issuable
CapitalContributionForSettlementOfStockIssuable
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"><b>NOTE 1. BUSINESS</b></p> <p style="font:8pt stHtmlOvrFontNm;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify">KwikClick, Inc., (the “Company” or “Kwik”) was organized pursuant to the laws of the State of Delaware on November 16, 1993. Beginning in 2020, the Company commenced its Kwik business operations to allow sellers to make products or services available on the Kwik platform, at Kwik.com, offering a self-determined incentive budget on goods or services in exchange for exposure and substantially increased sales volume. Kwik is a social interaction, selling, and referral software platform.  </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"><b>Use of Estimates</b></p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify"> </p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;background-color:#FFFFFF;text-align:justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2423983 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
us-gaap Revenue Recognition Sales Returns
RevenueRecognitionSalesReturns
<p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000"><span style="background-color:#FFFFFF"><b>Return Allowances</b></span></p> <p style="font:13.5pt stHtmlOvrFontNm;margin:0;color:#000000"> </p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF">The fees earned by the Company are subject to returns under similar terms as set by the third-party services using the Company’s software platform.  The Company does not assume responsibility for refund or replacement of product </span></p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"><span style="font-size:10pt;background-color:#FFFFFF">costs.  Return allowances are estimated using historical experience.  During the six months ended June 30, 2023 and 2022, the Company did not incur material returns.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF"><b>Reclassifications</b></span></p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt stHtmlOvrFontNm;margin:0;color:#000000;text-align:justify"><span style="color:#374151">The </span><span style="background-color:#FFFFFF">Company reclassified certain general and administrative and management and payroll costs totaling approximately $272,040 and $669,297 to research and development in the consolidated statements of operations for the three and six months ended June 30, 2022 to conform to the current period presentation. These reclassifications did not have any impact on the previously reported financial position, results of operations, or cash flows. </span></p>
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
272040 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
669297 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8150292 usd
CY2023Q2 fil Working Capital Deficit
WorkingCapitalDeficit
2049072 usd
fil Proceeds From Common Stock Issuable
ProceedsFromCommonStockIssuable
300000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3600000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1200000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.10
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2400000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5000000 shares
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
500000 usd
CY2023Q2 fil Unrecognized Compensation Associated With The Unvested Portion Of The Award
UnrecognizedCompensationAssociatedWithTheUnvestedPortionOfTheAward
240000 usd
CY2023Q2 fil Committed Shares For The Fulfillment Of Vested Awards
CommittedSharesForTheFulfillmentOfVestedAwards
23983 shares
CY2023Q2 fil Committed Shares For The Fulfillment Of Unvested Awards
CommittedSharesForTheFulfillmentOfUnvestedAwards
2400000 shares
CY2023Q2 fil Committed Shares For The Fulfillment Of Fully Vested Warrant Awards
CommittedSharesForTheFulfillmentOfFullyVestedWarrantAwards
102470 shares
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
26694 usd
fil Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
520261 usd
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
779739 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
12824 usd
us-gaap Interest Expense
InterestExpense
13108 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
kwik-20230630_cal.xml Edgar Link unprocessable
kwik-20230630_def.xml Edgar Link unprocessable
0001096906-23-001604-index-headers.html Edgar Link pending
0001096906-23-001604-index.html Edgar Link pending
0001096906-23-001604.txt Edgar Link pending
0001096906-23-001604-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kwik-20230630.htm Edgar Link pending
kwik-20230630.xsd Edgar Link pending
kwik_ex31z1.htm Edgar Link pending
kwik-20230630_lab.xml Edgar Link unprocessable
kwik-20230630_pre.xml Edgar Link unprocessable
kwik-20230630_htm.xml Edgar Link completed
kwik_ex31z2.htm Edgar Link pending
kwik_ex32z1.htm Edgar Link pending
kwik_ex32z2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending